Cure Alzheimer's Fund Achieves a Milestone with 1,000th Research Grant Award

The Cure Alzheimer's Fund (CureAlz), a nonprofit organization devoted to impactful research aimed at Alzheimer's prevention and cure, has reached an impressive milestone by awarding its 1,000th research grant. This moment highlights the organization's unwavering commitment to advancing scientific endeavors that strive to find effective treatments and potential cures for Alzheimer's disease.

Henry McCance, co-founder and chair of Cure Alzheimer's Fund, remarked on this achievement: "From the beginning, our vision was to accelerate the science that could change the course of Alzheimer's. Awarding our 1,000th grant is not merely a line in our history but a testimony to the relentless dedication of our scientists, the kindness of our donors, and a shared belief that we can provide hope to millions of families affected by this heartbreaking disease."

Since its inception in 2004, Cure Alzheimer's Fund has supported crucial initiatives in the field of Alzheimer's research. Notably, they have played a significant role in projects like the Alzheimer's Genome Project™, which revealed previously unidentified genes associated with the disease. They have also pioneered "Alzheimer's in a Dish," a groundbreaking 3-D human cell model that expedites the evaluation of potential therapies. Furthermore, CureAlz has created collaborative groups focusing on key elements like tau pathology, the APOE gene, neuroimmune response, and the blood-brain barrier, among others. Recent efforts include investigating the microbiome's role and studying brain aging. These pioneering projects are not just changing the scientific landscape surrounding Alzheimer's but are also paving the way for innovative treatments and long-term solutions.

"Achieving our 1,000th grant is both a remarkable success and a potent reminder of the rationale behind our existence," stated Meg Smith, CEO of Cure Alzheimer's Fund. "This landmark reflects not only the quantity of grants but also the rigorous science that guides our efforts. Each grant supports the most promising avenues of Alzheimer's research, showcasing the exceptional contributions of scientists who are making substantial progress against a disease that touches millions. Our resolve is strengthened by what we have accomplished thus far, and we remain committed to our mission until Alzheimer's disease is vanquished."

Cure Alzheimer's Fund stands out for its commitment to dedicated funding. The organization has allocated over $235 million to more than 300 leading researchers worldwide. Impressively, it has consistently received a perfect score and a Four-Star rating from Charity Navigator for 13 consecutive years, demonstrating its financial integrity and commitment to research funding. The board of directors and a group of dedicated donors ensure that all general donations directly support the research program, covering overhead costs separately.

As the world grapples with the rising prevalence of Alzheimer’s disease, organizations like Cure Alzheimer's Fund play a vital role in illuminating the path toward potential solutions. Those interested in learning more about their initiatives or wishing to support their critical work can visit their website at CureAlz.org. In a time of uncertainty, CureAlz remains a beacon of hope for millions impacted by Alzheimer’s disease, continuously striving for advancements that could one day change the lives of individuals and families across the globe.